Ten-Year Outcomes of Operable Solitary Hepatocellular Carcinoma Patients: Impact of Tumor Size Over 6.5 Cm and Microvascular Invasion
Chang Gung Memorial Hospital
3,000 participants
Sep 30, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this study is to evaualte the impact of tumor size and microvascular invasion among patients with solitary hepatocellualr carcinoma and post operation. The main questions it aims to answer are: Does the tumor size have more impact on the survival and recurrence than microvascular invasion among solitary operable hepatocellular carcinoma patients? Researchers will retrospectively analyze the prospectively collected clinical database during January 2022 and December 2019 to see whether tumor size more than 6.5 cm or microvascular invasion. The solitary operable hepatocellular carcinoma patients would be classified based on the status of microvascular invasion and tumor size, and the outcome would be evaluated among different sub-populations of the feasible subjects.
Eligibility
Inclusion Criteria1
- Operable solitary hepatocellular carcinoma
Exclusion Criteria3
- Not pT1N0M0 or pT2N0M0
- Missing tumor size
- Errors in survival/recurrence dates or status
Interventions
Surgery for HCC larger than 6.5 cm without mVI
Surgery for HCC larger than 2 cm with mVI
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06628661